Tag Archives: Sanofi SA

Johnson & Johnson (NYSE:JNJ) Profit Outshines Wall Street Estimates – JNJ, SNY, MYL, CNMD

Posted on April 17, 2013 by Thomas Vedder

Johnson & Johnson (NYSE:JNJ) announced on Tuesday that profit in fiscal Q1 plunged from previous year. However results surpassed forecasts on strong pharmaceutical sales.

Healthcare giant announced net earnings moved down to $3.5 billion or $1.22 a share from previous …

Posted in Healthcare, Latest Headlines | Tagged CNMD, CONMED, JNJ, Johnson, MYL, Mylan, NASDAQ:CNMD, NASDAQ:MYL, NYSE:JNJ, NYSE:SNY, Sanofi SA, SNY | Comments Off

Sanofi (NYSE:SNY) to Build New Plant in Vietnam to Meet Higher Demand; $75 Million Plan – SNY, BMY, GSK, MRK

Posted on April 1, 2013 by Thomas Vedder

Sanofi SA (ADR) (NYSE:SNY) announced on Friday that it will invest $75 million in a new facility in Vietnam to meet higher demand in the country for pharmaceuticals and consumer healthcare products.

French pharmaceutical company announced on Friday that the …

Posted in Healthcare, Latest Headlines | Tagged BMY, Bristol-Myers Squibb, GlaxoSmithKline, GSK, Merck, MRK, NYSE:BMY, NYSE:GSK, NYSE:MRK, NYSE:SNY, Sanofi SA, SNY | Comments Off

Higher Prices Leads Packaging Corp (NYSE:PKG) to Post 54% Boost in Fiscal Q4 Earnings – PKG, IP, RKT, PBI, CROX, TSN, KO, SNY, GM

Posted on January 22, 2013 by Thomas Vedder

Packaging Corp Of America (NYSE:PKG) price boost assisted the company to lift its fiscal Q4 earnings by 54% however the company warned it projects to incur higher operating outlays in the Q1.

The corrugated box maker also estimates present quarter …

Posted in Conglomerates, Latest Headlines | Tagged Coca Cola, Crocs, CROX, General Motors, GM, International Paper, IP, KO, NASDAQ:CROX, NYSE:GM, NYSE:IP, NYSE:KO, NYSE:PBI, NYSE:PKG, NYSE:RKT, NYSE:SNY, NYSE:TSN, Packaging Corp Of America, PBI, Pitney Bowes, PKG, RKT, Rock-Tenn, Sanofi SA, SNY, TSN, Tyson Foods | Comments Off

Eli Lilly & Co (NYSE:LLY) Expects Higher Earnings in 2013; Backs FY 2012 Outlook – LLY, GSK, SNY, JNJ

Posted on January 7, 2013 by Geoff Noir

Eli Lilly & Co (NYSE:LLY) maintained its earnings forecast for fiscal year 2012 on Friday regardless of the deferral of a projected tax benefit to the coming year. Eli Lilly estimates fiscal 2013 earnings to be over analysts’ forecasts even …

Posted in Healthcare, Latest Headlines | Tagged Eli Lilly, GlaxoSmithKline, GSK, JNJ, Johnson, LLY, NYSE:GSK, NYSE:JNJ, NYSE:LLY, NYSE:SNY, Sanofi SA, SNY | Comments Off

Eli Lilly (NYSE:LLY) Offers Better Than Expected Earning Guidance; Stock Hikes

Posted on January 5, 2013 by Geoff Noir

Eli Lilly & Co’s (NYSE:LLY) stock hiked by almost 4% on Friday after the pharmaceutical company offered a 2013 forecasts that expected better-than-anticipated earnings for the neat year.

The drug-making giant reported that it presently estimates full-year adjusted earnings in …

Posted in Healthcare, Main Post | Tagged Eli Lilly, GlaxoSmithKline, GSK, LLY, NASDAQ:VNDA, NYSE:GSK, NYSE:LLY, NYSE:SNY, Sanofi SA, SNY, Vanda Pharmaceuticals, VNDA | Comments Off

Healthcare Sector Summary; Johnson & Johnson (JNJ) Fails to Offer Data on Sanofi (SNY) Deal while Teva Pharmaceutical (TEVA) Retreats from Lower Valuation – JNJ, SNY, TEVA, FOLD, ARRY, JNJ

Posted on December 28, 2012 by Geoff Noir

Healthcare sector reacted negatively on Thursday’s trading session and sector slightly tumbled. If we look at the top movers of the sector so Amicus Therapeutics, Inc (NASDAQ:FOLD) and Array Biopharma Inc (NASDAQ:ARRY) were major percentage gainer while most active stock …

Posted in Healthcare, Latest Headlines | Tagged Amicus Therapeutics, Array BioPharma, ARRY, FOLD, JNJ, Johnson, NASDAQ:ARRY, NASDAQ:FOLD, NYSE:JNJ, NYSE:SNY, NYSE:TEVA, Sanofi SA, SNY, TEVA, Teva Pharmaceutical | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.